Elevation Oncology, Inc. (ELEV)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Elevation Oncology, Inc. (ELEV)
Company Performance

Current Price

as of Oct 16, 2024

$0.55

P/E Ratio

N/A

Market Cap

$32.64M

Description

Elevation Oncology, Inc. is a precision oncology company, which engages in the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. The firm’s program is focused on patients with advanced solid tumors harboring an NRG1 fusion. The company was founded by Shawn M. Leland in 2019 and is headquartered in Boston, MA.

Metrics

Overview

  • HQBoston, MA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerELEV
  • Price$0.5522+6.40%

Trading Information

  • Market Cap$32.64M
  • Float84.57%
  • Average Daily Volume (1m)718,746
  • Average Daily Volume (3m)1,130,989
  • EPS-$0.84

Company

  • RevenueN/A
  • Rev Growth (1yr)N/A
  • Net Income-$10.46M
  • Gross MarginN/A
  • EBITDA MarginN/A
  • EBITDA-$10.96M
  • EV$79.42M
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
  • P/B0.37
Documents